Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,996,473
-
Share change
-
+650,072
-
Total reported value
-
$1,555,378,737
-
Put/Call ratio
-
11%
-
Price per share
-
$111.14
-
Number of holders
-
86
-
Value change
-
+$76,084,134
-
Number of buys
-
46
-
Number of sells
-
46
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q3 2020
As of 30 Sep 2020,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,996,473 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., York Capital Management Global Advisors, LLC, Temasek Holdings (Private) Ltd, BANK OF AMERICA CORP /DE/, Maso Capital Partners Ltd, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, CAPSTONE INVESTMENT ADVISORS, LLC, BlackRock Inc., and Pentwater Capital Management LP.
This page lists
86
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.